Other Locations
Baton Rouge General
8585 Picardy Avenue
Baton Rouge, Louisiana
70809
Baton Rouge, Louisiana
70809
Phone
(985) 542-5000
Fax
(985) 542-1138
feedback@marybird.com
Michael Dzeda, M.D.
- Radiation Oncology
Mary Bird Provider
Dr. Michael Dzeda is a board-certified radiation oncologist, serving patients at Mary Bird Perkins Cancer Center locations in Hammond and at Baton Rouge General. With a focus on advanced, compassionate cancer care, he brings decades of clinical experience and a strong academic foundation to his role.
Dr. Dzeda is a 1991 graduate of Louisiana State University School of Medicine in New Orleans. Prior to earning his medical degree, he completed undergraduate degrees in both microbiology and zoology at LSU in Baton Rouge and pursued master’s-level coursework and training in medical physics. He completed an internal medicine internship at LSU Allied Hospital in New Orleans and a residency in radiation oncology at Hahnemann University Hospital in Philadelphia, Pennsylvania.
Dr. Dzeda was awarded an American Cancer Society Clinical Oncology Fellowship in recognition of his achievements in the field. He is a Diplomate of the American Board of Radiology and has served as a selected peer reviewer for the American Journal of Clinical Oncology. Additionally, he co-authored the chapter on radiation treatment of benign disease in one of the leading textbooks in radiation oncology. Dr. Dzeda has chaired multiple committees in Health Policy for ASTRO (American Society for Radiation Oncology), the leading professional society of radiation oncology.
He has a special interest in treating head and neck, breast and skin malignancies. Additionally, he has experience treating patients with benign diseases, including Dupuyten’s disease and plantar fibromas. Dr. Dzeda is a member of several professional organizations, including the American Society for Radiation Oncology, the Medical Society of Delaware, and the Delaware Society of Clinical Oncology.
Affiliations
Mary Bird Perkins Cancer Center
Experience & Training
Internship: Louisiana State University Allied Hospital; Internal Medicine; New Orleans, La
Residency: Hahnemann University Hospital; Radiation Oncology; Philadelphia, Pa
Helen F. Graham Cancer Center, Newark, DE
Education
Bachelors: Louisiana State University; Baton Rouge, La
Medical: Louisiana State University School of Medicine; New Orleans, La
Certifications
Diplomate of the American Board of Radiology
Board Certified in Radiation Oncology
National Board of Medical Examiners
Publications
Bundalevski I, Harrison AS, Dzeda MF, Doyle LA, Chen H: Use of 3D Printing Technology to Improve Lead Shield Fabrication for Electron Therapy of the Face. Practical Radiation Oncology, accepted for publication, 2025
Sherman EJ, Harris J, Bible KC, Ghossein RA, Chung CH, Riaz N, Gunn B, Foote RL, Yom S, Wong SJ, Dzeda MF, Clump DA, Khan S, Chakravarti A, Redmond K, TorresSaavedra P, Le Q-T, Lee N: Randomized phase II study of radiation therapy and paclitaxel with pazopanib or placebo: NRG-RTOG 0912. Annals of Oncology, Vol 3: Supp 4: September 2020.
A. Raben 1, J.D. Palmer 2, J. Strasser 1, A. Hanlon 3, M. Dzeda 1, N. Hockstein 4, C.J. Schneider: Combination of RT and cetuximab for aggressive, high-risk CSCC of h&n: a propensity score analysis with first (presenting author) 5 accepted for presentation as E-poster for ESTRO 35, Turin, Italy from 29 April-3 May 2016.
Adam Raben3, Tu Dan1, David Raben2, Charles Schneider3, Neil Hockstein3, Michael Dzeda3, Jennifer Cormier3, Robert Witt3: Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: Updated results of an institutional clinical management approach. Ref.: Ms. No. OO-D-14-750R1 (Manuscript accepted for publication, Oncology, Elsevier)
Joshua D. Palmer, MD, Jon Strasser, MD, Alexandra L. Hanlon, PhD, Jordan Silberg, BS, Elizabeth A. Mauer, MS, Michael Dzeda, MD, Neil Hockstein, MD, Robert Witt, MD, Charles J. Schneider, MD, Adam Raben, MD: Combination of radiotherapy and cetuximab for highrisk/very high-risk cutaneous squamous cell cancer of the head and neck: a propensity score analysis: Presented, ASCO 2015. American Radium Society’s 97th Annual Meeting
Contributing author to The ASTRO/ACR Guide to Radiation Oncology Coding 2007
Raben A, Tribius S, Schneider C, Witt R, Sammons S, Hanlon A, Dzeda M, Andreou A. Feasibility report of IMRT and chemotherapy for advanced cancers of the head and neck: results of the first 50 cases treated at a community practice in the USA. Poster , ESTRO, October 2006, Leipzig Germany